The publisher's “United Kingdom General Surgery Device Procedures Outlook to 2030' is a comprehensive databook report, covering key procedures data on the United Kingdom General Surgery Device Procedures. The databook report provides procedure volumes within segments - Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others.
The United Kingdom General Surgery Device Procedures report provides key information and data on:
The United Kingdom General Surgery Device Procedures report provides key information and data on:
- Procedure volume data for General Surgery Device Procedures related to the country. Data is provided from 2015 to 2030
Scope
United Kingdom General Surgery Device Procedures is segmented as follows:- Airway Stent Procedures
- Bariatric Surgery Procedures
- Biopsy Procedures
- Hernia Repair Procedures
- Prostatectomy Procedures
- Cholecystectomy Procedures
- Colectomy Procedures
- Embolization Particle Procedures
- Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures
- Hysterectomy Procedures
- Myomectomy Procedures
- Percutaneous Drainage Procedures
- Procedures Performed Using External Surgical Stapling Devices
- Procedures Performed Using Internal Surgical Stapling Device
- Prostatectomy Procedures
- Reconstruction Meshes Procedures
Reasons to Buy
United Kingdom General Surgery Device Procedures report helps you to develop:- Business strategies by identifying the key segments poised for strong growth in the future
- Market-entry and market expansion strategies
- Develop investment strategies by identifying the key segments expected to register strong growth in the near future.
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 General Surgery Devices, Segmentation
2.3 Definitions of Procedures Covered in the Report
2.2 General Surgery Devices, Segmentation
2.3 Definitions of Procedures Covered in the Report
3 General Surgery Devices, United Kingdom
3.1 General Surgery Devices, United Kingdom, 2015-2030
3.2 General Surgery Devices, United Kingdom, 2015-2030
3.2 General Surgery Devices, United Kingdom, 2015-2030
4 Airway Stent Procedures, United Kingdom
4.1 Airway Stent Procedures, United Kingdom, 2015-2030
4.1.1 Airway Stenting Procedures for Other Indications, United Kingdom, 2015-2030
4.1.2 Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2015-2030
4.1.1 Airway Stenting Procedures for Other Indications, United Kingdom, 2015-2030
4.1.2 Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2015-2030
5 Bariatric Surgery Procedures, United Kingdom
5.1 Bariatric Surgery Procedures, United Kingdom, 2015-2030
6 Biopsy Procedures, United Kingdom
6.1 Biopsy Procedures, United Kingdom, 2015-2030
6.1.1 Biopsy Procedures for Other Indications, United Kingdom, 2015-2030
6.1.2 Breast Biopsy Procedures, United Kingdom, 2015-2030
6.1.3 Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2015-2030
6.1.4 Cirrhosis Biopsy Procedures, United Kingdom, 2015-2030
6.1.5 Colorectal Biopsy Procedures, United Kingdom, 2015-2030
6.1.6 Kidney Transplant Biopsy Procedures, United Kingdom, 2015-2030
6.1.7 Leukemia Biopsy Procedures, United Kingdom, 2015-2030
6.1.8 Liver Biopsy Procedures, United Kingdom, 2015-2030
6.1.9 Liver Transplant Biopsy Procedures, United Kingdom, 2015-2030
6.1.10 Lung Biopsy Procedures, United Kingdom, 2015-2030
6.1.11 Prostate Biopsy Procedures, United Kingdom, 2015-2030
6.1.12 Skin Biopsy Procedures, United Kingdom, 2015-2030
6.1.13 Thyroid Biopsy Procedures, United Kingdom, 2015-2030
6.1.1 Biopsy Procedures for Other Indications, United Kingdom, 2015-2030
6.1.2 Breast Biopsy Procedures, United Kingdom, 2015-2030
6.1.3 Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2015-2030
6.1.4 Cirrhosis Biopsy Procedures, United Kingdom, 2015-2030
6.1.5 Colorectal Biopsy Procedures, United Kingdom, 2015-2030
6.1.6 Kidney Transplant Biopsy Procedures, United Kingdom, 2015-2030
6.1.7 Leukemia Biopsy Procedures, United Kingdom, 2015-2030
6.1.8 Liver Biopsy Procedures, United Kingdom, 2015-2030
6.1.9 Liver Transplant Biopsy Procedures, United Kingdom, 2015-2030
6.1.10 Lung Biopsy Procedures, United Kingdom, 2015-2030
6.1.11 Prostate Biopsy Procedures, United Kingdom, 2015-2030
6.1.12 Skin Biopsy Procedures, United Kingdom, 2015-2030
6.1.13 Thyroid Biopsy Procedures, United Kingdom, 2015-2030
7 Cholecystectomy Procedures, United Kingdom
7.1 Cholecystectomy Procedures, United Kingdom, 2015-2030
8 Colectomy Procedures, United Kingdom
8.1 Colectomy Procedures, United Kingdom, 2015-2030
9 Embolization Particle Procedures, United Kingdom
9.1 Embolization Particle Procedures, United Kingdom, 2015-2030
9.1.1 Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2015-2030
9.1.2 Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2015-2030
9.1.3 Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2015-2030
9.1.4 Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2015-2030
9.1.5 Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2015-2030
9.1.6 Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2015-2030
9.1.7 Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2015-2030
9.1.8 Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2015-2030
9.1.9 Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2015-2030
9.1.1 Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2015-2030
9.1.2 Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2015-2030
9.1.3 Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2015-2030
9.1.4 Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2015-2030
9.1.5 Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2015-2030
9.1.6 Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2015-2030
9.1.7 Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2015-2030
9.1.8 Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2015-2030
9.1.9 Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2015-2030
10 Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom
10.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2015-2030
11 Enteral Stenting Procedures, United Kingdom
11.1 Enteral Stenting Procedures, United Kingdom, 2015-2030
12 Hernia Repair Procedures, United Kingdom
12.1 Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.1 Femoral Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.2 Incisional Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.3 Inguinal Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.4 Other Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.5 Umbilical Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.1 Femoral Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.2 Incisional Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.3 Inguinal Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.4 Other Hernia Repair Procedures, United Kingdom, 2015-2030
12.1.5 Umbilical Hernia Repair Procedures, United Kingdom, 2015-2030
13 Hysterectomy Procedures, United Kingdom
13.1 Hysterectomy Procedures, United Kingdom, 2015-2030
14 Myomectomy Procedures, United Kingdom
14.1 Myomectomy Procedures, United Kingdom, 2015-2030
15 Percutaneous drainage procedures, United Kingdom
15.1 Percutaneous drainage procedures, United Kingdom, 2015-2030
15.1.1 Percutaneous drainage procedures for Abscess Drainage, United Kingdom, 2015-2030
15.1.2 Percutaneous drainage procedures for Biliary Drainage, United Kingdom, 2015-2030
15.1.3 Percutaneous drainage procedures for Nephrostomy Drainage, United Kingdom, 2015-2030
15.1.4 Percutaneous drainage procedures for Paracentesis, United Kingdom, 2015-2030
15.1.5 Percutaneous drainage procedures for Thoracentesis, United Kingdom, 2015-2030
15.1.1 Percutaneous drainage procedures for Abscess Drainage, United Kingdom, 2015-2030
15.1.2 Percutaneous drainage procedures for Biliary Drainage, United Kingdom, 2015-2030
15.1.3 Percutaneous drainage procedures for Nephrostomy Drainage, United Kingdom, 2015-2030
15.1.4 Percutaneous drainage procedures for Paracentesis, United Kingdom, 2015-2030
15.1.5 Percutaneous drainage procedures for Thoracentesis, United Kingdom, 2015-2030
16 Procedures performed using External Surgical Stapling Devices, United Kingdom
16.1 Procedures performed using External Surgical Stapling Devices, United Kingdom, 2015-2030
17 Procedures performed using Internal Surgical Stapling Devices, United Kingdom
17.1 Procedures performed using Internal Surgical Stapling Devices, United Kingdom, 2015-2030
17.1.1 Internal Surgical Stapling procedures performed using Open Surgical Stapling Devices, United Kingdom, 2015-2030
17.1.1 Internal Surgical Stapling procedures performed using Open Surgical Stapling Devices, United Kingdom, 2015-2030
18 Prostatectomy Procedures, United Kingdom
18.1 Prostatectomy Procedures, United Kingdom, 2015-2030
19 Reconstruction Meshes Procedures, United Kingdom
19.1 Reconstruction Meshes Procedures, United Kingdom, 2015-2030
20 Appendix
20.1 Research Methodology
20.1.1 Coverage
20.1.2 Secondary Research
20.1.3 Primary Research
20.1.4 Market Modeling and Forecasting
20.1.5 Company Share Analysis
20.1.6 Distribution Share Analysis
20.1.7 Benchmarking
20.2 Publisher Consulting
20.3 Contact the Publisher
20.4 Disclaimer
20.1.1 Coverage
20.1.2 Secondary Research
20.1.3 Primary Research
20.1.4 Market Modeling and Forecasting
20.1.5 Company Share Analysis
20.1.6 Distribution Share Analysis
20.1.7 Benchmarking
20.2 Publisher Consulting
20.3 Contact the Publisher
20.4 Disclaimer
List of Tables
Table 1: General Surgery Devices, United Kingdom, 2015-2030
Table 2: General Surgery Devices, United Kingdom, 2015-2022
Table 3: General Surgery Devices, United Kingdom, 2023-2030
Table 4: Airway Stent Procedures, United Kingdom, 2015-2022
Table 5: Airway Stent Procedures, United Kingdom, 2023-2030
Table 6: Airway Stenting Procedures for Other Indications, United Kingdom, 2015-2022
Table 7: Airway Stenting Procedures for Other Indications, United Kingdom, 2023-2030
Table 8: Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2015-2022
Table 9: Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2023-2030
Table 10: Bariatric Surgery Procedures, United Kingdom, 2015-2022
Table 11: Bariatric Surgery Procedures, United Kingdom, 2023-2030
Table 12: Biopsy Procedures, United Kingdom, 2015-2022
Table 13: Biopsy Procedures, United Kingdom, 2023-2030
Table 14: Biopsy Procedures for Other Indications, United Kingdom, 2015-2022
Table 15: Biopsy Procedures for Other Indications, United Kingdom, 2023-2030
Table 16: Breast Biopsy Procedures, United Kingdom, 2015-2022
Table 17: Breast Biopsy Procedures, United Kingdom, 2023-2030
Table 18: Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2015-2022
Table 19: Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2023-2030
Table 20: Cirrhosis Biopsy Procedures, United Kingdom, 2015-2022
Table 21: Cirrhosis Biopsy Procedures, United Kingdom, 2023-2030
Table 22: Colorectal Biopsy Procedures, United Kingdom, 2015-2022
Table 23: Colorectal Biopsy Procedures, United Kingdom, 2023-2030
Table 24: Kidney Transplant Biopsy Procedures, United Kingdom, 2015-2022
Table 25: Kidney Transplant Biopsy Procedures, United Kingdom, 2023-2030
Table 26: Leukemia Biopsy Procedures, United Kingdom, 2015-2022
Table 27: Leukemia Biopsy Procedures, United Kingdom, 2023-2030
Table 28: Liver Biopsy Procedures, United Kingdom, 2015-2022
Table 29: Liver Biopsy Procedures, United Kingdom, 2023-2030
Table 30: Liver Transplant Biopsy Procedures, United Kingdom, 2015-2022
Table 31: Liver Transplant Biopsy Procedures, United Kingdom, 2023-2030
Table 32: Lung Biopsy Procedures, United Kingdom, 2015-2022
Table 33: Lung Biopsy Procedures, United Kingdom, 2023-2030
Table 34: Prostate Biopsy Procedures, United Kingdom, 2015-2022
Table 35: Prostate Biopsy Procedures, United Kingdom, 2023-2030
Table 36: Skin Biopsy Procedures, United Kingdom, 2015-2022
Table 37: Skin Biopsy Procedures, United Kingdom, 2023-2030
Table 38: Thyroid Biopsy Procedures, United Kingdom, 2015-2022
Table 39: Thyroid Biopsy Procedures, United Kingdom, 2023-2030
Table 40: Cholecystectomy Procedures, United Kingdom, 2015-2022
Table 41: Cholecystectomy Procedures, United Kingdom, 2023-2030
Table 42: Colectomy Procedures, United Kingdom, 2015-2022
Table 43: Colectomy Procedures, United Kingdom, 2023-2030
Table 44: Embolization Particle Procedures, United Kingdom, 2015-2022
Table 45: Embolization Particle Procedures, United Kingdom, 2023-2030
Table 46: Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2015-2022
Table 47: Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2023-2030
Table 48: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2015-2022
Table 49: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2023-2030
Table 50: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2015-2022
Table 51: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2023-2030
Table 52: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2015-2022
Table 53: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2023-2030
Table 54: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2015-2022
Table 55: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2023-2030
Table 56: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2015-2022
Table 57: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2023-2030
Table 58: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2015-2022
Table 59: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2023-2030
Table 60: Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2015-2022
Table 61: Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2023-2030
Table 62: Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2015-2022
Table 63: Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2023-2030
Table 64: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2015-2022
Table 65: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2023-2030
Table 66: Enteral Stenting Procedures, United Kingdom, 2015-2022
Table 67: Enteral Stenting Procedures, United Kingdom, 2023-2030
Table 68: Hernia Repair Procedures, United Kingdom, 2015-2022
Table 69: Hernia Repair Procedures, United Kingdom, 2023-2030
Table 70: Femoral Hernia Repair Procedures, United Kingdom, 2015-2022
Table 71: Femoral Hernia Repair Procedures, United Kingdom, 2023-2030
Table 72: Incisional Hernia Repair Procedures, United Kingdom, 2015-2022
Table 73: Incisional Hernia Repair Procedures, United Kingdom, 2023-2030
Table 74: Inguinal Hernia Repair Procedures, United Kingdom, 2015-2022
Table 75: Inguinal Hernia Repair Procedures, United Kingdom, 2023-2030
Table 76: Other Hernia Repair Procedures, United Kingdom, 2015-2022
Table 77: Other Hernia Repair Procedures, United Kingdom, 2023-2030
Table 78: Umbilical Hernia Repair Procedures, United Kingdom, 2015-2022
Table 79: Umbilical Hernia Repair Procedures, United Kingdom, 2023-2030
Table 80: Hysterectomy Procedures, United Kingdom, 2015-2022
Table 81: Hysterectomy Procedures, United Kingdom, 2023-2030
Table 82: Myomectomy Procedures, United Kingdom, 2015-2022
Table 2: General Surgery Devices, United Kingdom, 2015-2022
Table 3: General Surgery Devices, United Kingdom, 2023-2030
Table 4: Airway Stent Procedures, United Kingdom, 2015-2022
Table 5: Airway Stent Procedures, United Kingdom, 2023-2030
Table 6: Airway Stenting Procedures for Other Indications, United Kingdom, 2015-2022
Table 7: Airway Stenting Procedures for Other Indications, United Kingdom, 2023-2030
Table 8: Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2015-2022
Table 9: Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2023-2030
Table 10: Bariatric Surgery Procedures, United Kingdom, 2015-2022
Table 11: Bariatric Surgery Procedures, United Kingdom, 2023-2030
Table 12: Biopsy Procedures, United Kingdom, 2015-2022
Table 13: Biopsy Procedures, United Kingdom, 2023-2030
Table 14: Biopsy Procedures for Other Indications, United Kingdom, 2015-2022
Table 15: Biopsy Procedures for Other Indications, United Kingdom, 2023-2030
Table 16: Breast Biopsy Procedures, United Kingdom, 2015-2022
Table 17: Breast Biopsy Procedures, United Kingdom, 2023-2030
Table 18: Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2015-2022
Table 19: Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2023-2030
Table 20: Cirrhosis Biopsy Procedures, United Kingdom, 2015-2022
Table 21: Cirrhosis Biopsy Procedures, United Kingdom, 2023-2030
Table 22: Colorectal Biopsy Procedures, United Kingdom, 2015-2022
Table 23: Colorectal Biopsy Procedures, United Kingdom, 2023-2030
Table 24: Kidney Transplant Biopsy Procedures, United Kingdom, 2015-2022
Table 25: Kidney Transplant Biopsy Procedures, United Kingdom, 2023-2030
Table 26: Leukemia Biopsy Procedures, United Kingdom, 2015-2022
Table 27: Leukemia Biopsy Procedures, United Kingdom, 2023-2030
Table 28: Liver Biopsy Procedures, United Kingdom, 2015-2022
Table 29: Liver Biopsy Procedures, United Kingdom, 2023-2030
Table 30: Liver Transplant Biopsy Procedures, United Kingdom, 2015-2022
Table 31: Liver Transplant Biopsy Procedures, United Kingdom, 2023-2030
Table 32: Lung Biopsy Procedures, United Kingdom, 2015-2022
Table 33: Lung Biopsy Procedures, United Kingdom, 2023-2030
Table 34: Prostate Biopsy Procedures, United Kingdom, 2015-2022
Table 35: Prostate Biopsy Procedures, United Kingdom, 2023-2030
Table 36: Skin Biopsy Procedures, United Kingdom, 2015-2022
Table 37: Skin Biopsy Procedures, United Kingdom, 2023-2030
Table 38: Thyroid Biopsy Procedures, United Kingdom, 2015-2022
Table 39: Thyroid Biopsy Procedures, United Kingdom, 2023-2030
Table 40: Cholecystectomy Procedures, United Kingdom, 2015-2022
Table 41: Cholecystectomy Procedures, United Kingdom, 2023-2030
Table 42: Colectomy Procedures, United Kingdom, 2015-2022
Table 43: Colectomy Procedures, United Kingdom, 2023-2030
Table 44: Embolization Particle Procedures, United Kingdom, 2015-2022
Table 45: Embolization Particle Procedures, United Kingdom, 2023-2030
Table 46: Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2015-2022
Table 47: Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2023-2030
Table 48: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2015-2022
Table 49: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2023-2030
Table 50: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2015-2022
Table 51: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2023-2030
Table 52: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2015-2022
Table 53: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2023-2030
Table 54: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2015-2022
Table 55: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2023-2030
Table 56: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2015-2022
Table 57: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2023-2030
Table 58: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2015-2022
Table 59: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2023-2030
Table 60: Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2015-2022
Table 61: Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2023-2030
Table 62: Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2015-2022
Table 63: Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2023-2030
Table 64: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2015-2022
Table 65: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2023-2030
Table 66: Enteral Stenting Procedures, United Kingdom, 2015-2022
Table 67: Enteral Stenting Procedures, United Kingdom, 2023-2030
Table 68: Hernia Repair Procedures, United Kingdom, 2015-2022
Table 69: Hernia Repair Procedures, United Kingdom, 2023-2030
Table 70: Femoral Hernia Repair Procedures, United Kingdom, 2015-2022
Table 71: Femoral Hernia Repair Procedures, United Kingdom, 2023-2030
Table 72: Incisional Hernia Repair Procedures, United Kingdom, 2015-2022
Table 73: Incisional Hernia Repair Procedures, United Kingdom, 2023-2030
Table 74: Inguinal Hernia Repair Procedures, United Kingdom, 2015-2022
Table 75: Inguinal Hernia Repair Procedures, United Kingdom, 2023-2030
Table 76: Other Hernia Repair Procedures, United Kingdom, 2015-2022
Table 77: Other Hernia Repair Procedures, United Kingdom, 2023-2030
Table 78: Umbilical Hernia Repair Procedures, United Kingdom, 2015-2022
Table 79: Umbilical Hernia Repair Procedures, United Kingdom, 2023-2030
Table 80: Hysterectomy Procedures, United Kingdom, 2015-2022
Table 81: Hysterectomy Procedures, United Kingdom, 2023-2030
Table 82: Myomectomy Procedures, United Kingdom, 2015-2022
List of Figures
Figure 1: General Surgery Devices, United Kingdom, 2015-2030
Figure 2: General Surgery Devices, United Kingdom, 2015-2022
Figure 3: General Surgery Devices, United Kingdom, 2023-2030
Figure 4: Airway Stent Procedures, United Kingdom, 2015-2022
Figure 5: Airway Stent Procedures, United Kingdom, 2023-2030
Figure 6: Airway Stenting Procedures for Other Indications, United Kingdom, 2015-2022
Figure 7: Airway Stenting Procedures for Other Indications, United Kingdom, 2023-2030
Figure 8: Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2015-2022
Figure 9: Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2023-2030
Figure 10: Bariatric Surgery Procedures, United Kingdom, 2015-2022
Figure 11: Bariatric Surgery Procedures, United Kingdom, 2023-2030
Figure 12: Biopsy Procedures, United Kingdom, 2015-2022
Figure 13: Biopsy Procedures, United Kingdom, 2023-2030
Figure 14: Biopsy Procedures for Other Indications, United Kingdom, 2015-2022
Figure 15: Biopsy Procedures for Other Indications, United Kingdom, 2023-2030
Figure 16: Breast Biopsy Procedures, United Kingdom, 2015-2022
Figure 17: Breast Biopsy Procedures, United Kingdom, 2023-2030
Figure 18: Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2015-2022
Figure 19: Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2023-2030
Figure 20: Cirrhosis Biopsy Procedures, United Kingdom, 2015-2022
Figure 21: Cirrhosis Biopsy Procedures, United Kingdom, 2023-2030
Figure 22: Colorectal Biopsy Procedures, United Kingdom, 2015-2022
Figure 23: Colorectal Biopsy Procedures, United Kingdom, 2023-2030
Figure 24: Kidney Transplant Biopsy Procedures, United Kingdom, 2015-2022
Figure 25: Kidney Transplant Biopsy Procedures, United Kingdom, 2023-2030
Figure 26: Leukemia Biopsy Procedures, United Kingdom, 2015-2022
Figure 27: Leukemia Biopsy Procedures, United Kingdom, 2023-2030
Figure 28: Liver Biopsy Procedures, United Kingdom, 2015-2022
Figure 29: Liver Biopsy Procedures, United Kingdom, 2023-2030
Figure 30: Liver Transplant Biopsy Procedures, United Kingdom, 2015-2022
Figure 31: Liver Transplant Biopsy Procedures, United Kingdom, 2023-2030
Figure 32: Lung Biopsy Procedures, United Kingdom, 2015-2022
Figure 33: Lung Biopsy Procedures, United Kingdom, 2023-2030
Figure 34: Prostate Biopsy Procedures, United Kingdom, 2015-2022
Figure 35: Prostate Biopsy Procedures, United Kingdom, 2023-2030
Figure 36: Skin Biopsy Procedures, United Kingdom, 2015-2022
Figure 37: Skin Biopsy Procedures, United Kingdom, 2023-2030
Figure 38: Thyroid Biopsy Procedures, United Kingdom, 2015-2022
Figure 39: Thyroid Biopsy Procedures, United Kingdom, 2023-2030
Figure 40: Cholecystectomy Procedures, United Kingdom, 2015-2022
Figure 41: Cholecystectomy Procedures, United Kingdom, 2023-2030
Figure 42: Colectomy Procedures, United Kingdom, 2015-2022
Figure 43: Colectomy Procedures, United Kingdom, 2023-2030
Figure 44: Embolization Particle Procedures, United Kingdom, 2015-2022
Figure 45: Embolization Particle Procedures, United Kingdom, 2023-2030
Figure 46: Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2015-2022
Figure 47: Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2023-2030
Figure 48: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2015-2022
Figure 49: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2023-2030
Figure 50: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2015-2022
Figure 51: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2023-2030
Figure 52: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2015-2022
Figure 53: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2023-2030
Figure 54: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2015-2022
Figure 55: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2023-2030
Figure 56: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2015-2022
Figure 57: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2023-2030
Figure 58: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2015-2022
Figure 59: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2023-2030
Figure 60: Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2015-2022
Figure 61: Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2023-2030
Figure 62: Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2015-2022
Figure 63: Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2023-2030
Figure 64: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2015-2022
Figure 65: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2023-2030
Figure 66: Enteral Stenting Procedures, United Kingdom, 2015-2022
Figure 67: Enteral Stenting Procedures, United Kingdom, 2023-2030
Figure 68: Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 69: Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 70: Femoral Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 71: Femoral Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 72: Incisional Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 73: Incisional Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 74: Inguinal Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 75: Inguinal Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 76: Other Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 77: Other Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 78: Umbilical Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 79: Umbilical Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 80: Hysterectomy Procedures, United Kingdom, 2015-2022
Figure 81: Hysterectomy Procedures, United Kingdom, 2023-2030
Figure 82: Myomectomy Procedures, United Kingdom, 2015-2022
Figure 83: Myomectomy Procedures, United Kingdom, 2023-2030
Figure 84: Percutaneous drainage procedures, United Kingdom, 2015-2022
Figure 85: Percutaneous drainage procedures, United Kingdom, 2023-2030
Figure 86: Percutaneous drainage procedures for Abscess Drainage, United Kingdom, 2015-2022
Figure 2: General Surgery Devices, United Kingdom, 2015-2022
Figure 3: General Surgery Devices, United Kingdom, 2023-2030
Figure 4: Airway Stent Procedures, United Kingdom, 2015-2022
Figure 5: Airway Stent Procedures, United Kingdom, 2023-2030
Figure 6: Airway Stenting Procedures for Other Indications, United Kingdom, 2015-2022
Figure 7: Airway Stenting Procedures for Other Indications, United Kingdom, 2023-2030
Figure 8: Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2015-2022
Figure 9: Malignant Airway Obstruction Stenting Procedures, United Kingdom, 2023-2030
Figure 10: Bariatric Surgery Procedures, United Kingdom, 2015-2022
Figure 11: Bariatric Surgery Procedures, United Kingdom, 2023-2030
Figure 12: Biopsy Procedures, United Kingdom, 2015-2022
Figure 13: Biopsy Procedures, United Kingdom, 2023-2030
Figure 14: Biopsy Procedures for Other Indications, United Kingdom, 2015-2022
Figure 15: Biopsy Procedures for Other Indications, United Kingdom, 2023-2030
Figure 16: Breast Biopsy Procedures, United Kingdom, 2015-2022
Figure 17: Breast Biopsy Procedures, United Kingdom, 2023-2030
Figure 18: Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2015-2022
Figure 19: Chronic Kidney Disease Biopsy Procedures, United Kingdom, 2023-2030
Figure 20: Cirrhosis Biopsy Procedures, United Kingdom, 2015-2022
Figure 21: Cirrhosis Biopsy Procedures, United Kingdom, 2023-2030
Figure 22: Colorectal Biopsy Procedures, United Kingdom, 2015-2022
Figure 23: Colorectal Biopsy Procedures, United Kingdom, 2023-2030
Figure 24: Kidney Transplant Biopsy Procedures, United Kingdom, 2015-2022
Figure 25: Kidney Transplant Biopsy Procedures, United Kingdom, 2023-2030
Figure 26: Leukemia Biopsy Procedures, United Kingdom, 2015-2022
Figure 27: Leukemia Biopsy Procedures, United Kingdom, 2023-2030
Figure 28: Liver Biopsy Procedures, United Kingdom, 2015-2022
Figure 29: Liver Biopsy Procedures, United Kingdom, 2023-2030
Figure 30: Liver Transplant Biopsy Procedures, United Kingdom, 2015-2022
Figure 31: Liver Transplant Biopsy Procedures, United Kingdom, 2023-2030
Figure 32: Lung Biopsy Procedures, United Kingdom, 2015-2022
Figure 33: Lung Biopsy Procedures, United Kingdom, 2023-2030
Figure 34: Prostate Biopsy Procedures, United Kingdom, 2015-2022
Figure 35: Prostate Biopsy Procedures, United Kingdom, 2023-2030
Figure 36: Skin Biopsy Procedures, United Kingdom, 2015-2022
Figure 37: Skin Biopsy Procedures, United Kingdom, 2023-2030
Figure 38: Thyroid Biopsy Procedures, United Kingdom, 2015-2022
Figure 39: Thyroid Biopsy Procedures, United Kingdom, 2023-2030
Figure 40: Cholecystectomy Procedures, United Kingdom, 2015-2022
Figure 41: Cholecystectomy Procedures, United Kingdom, 2023-2030
Figure 42: Colectomy Procedures, United Kingdom, 2015-2022
Figure 43: Colectomy Procedures, United Kingdom, 2023-2030
Figure 44: Embolization Particle Procedures, United Kingdom, 2015-2022
Figure 45: Embolization Particle Procedures, United Kingdom, 2023-2030
Figure 46: Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2015-2022
Figure 47: Embolization Particle Procedures to treat Arteriovenous Malformations, United Kingdom, 2023-2030
Figure 48: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2015-2022
Figure 49: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United Kingdom, 2023-2030
Figure 50: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2015-2022
Figure 51: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United Kingdom, 2023-2030
Figure 52: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2015-2022
Figure 53: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United Kingdom, 2023-2030
Figure 54: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2015-2022
Figure 55: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United Kingdom, 2023-2030
Figure 56: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2015-2022
Figure 57: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United Kingdom, 2023-2030
Figure 58: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2015-2022
Figure 59: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United Kingdom, 2023-2030
Figure 60: Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2015-2022
Figure 61: Embolization Particle Procedures to treat Renal Cell Carcinoma, United Kingdom, 2023-2030
Figure 62: Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2015-2022
Figure 63: Embolization Particle Procedures to treat Uterine Fibroids, United Kingdom, 2023-2030
Figure 64: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2015-2022
Figure 65: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United Kingdom, 2023-2030
Figure 66: Enteral Stenting Procedures, United Kingdom, 2015-2022
Figure 67: Enteral Stenting Procedures, United Kingdom, 2023-2030
Figure 68: Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 69: Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 70: Femoral Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 71: Femoral Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 72: Incisional Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 73: Incisional Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 74: Inguinal Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 75: Inguinal Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 76: Other Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 77: Other Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 78: Umbilical Hernia Repair Procedures, United Kingdom, 2015-2022
Figure 79: Umbilical Hernia Repair Procedures, United Kingdom, 2023-2030
Figure 80: Hysterectomy Procedures, United Kingdom, 2015-2022
Figure 81: Hysterectomy Procedures, United Kingdom, 2023-2030
Figure 82: Myomectomy Procedures, United Kingdom, 2015-2022
Figure 83: Myomectomy Procedures, United Kingdom, 2023-2030
Figure 84: Percutaneous drainage procedures, United Kingdom, 2015-2022
Figure 85: Percutaneous drainage procedures, United Kingdom, 2023-2030
Figure 86: Percutaneous drainage procedures for Abscess Drainage, United Kingdom, 2015-2022
